Latest / This Week In Medicine
NEJM January 8, 2026 RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
This research study evaluates the impact of a specific bivalent vaccine on reducing severe illness from respiratory syncytial virus (RSV) among individuals aged 60 and older. By comparing a large group of vaccinated seniors against an unvaccinated control group during a winter season, researchers discovered that the immunization offered significant protection against serious complications. The data specifically highlights that the vaccine was highly effective at preventing hospitalizations linked to both general and lower respiratory infections caused by the virus. Ultimately, the findings…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.